e.demir
Submits third-party assay reports on material purchased directly. Based in Galway.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.62%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043178 | Kisspeptin-10 | GL Biochem | GLBI-2608-N7715 | Janoshik | 2026-Q3 | 98.50 | 4.55 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043022 | Adipotide | MKM | MKM-2606-K5012 | Kestrel | 2026-Q3 | 97.69 | 6.33 | 106.9 | Buyer-sourced | 0 | PASS |
| AX-2026-043379 | Semaglutide | WXT | WXT-2604-C3248 | VendorInvestigate | 2026-Q3 | 96.58 | 3.78 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043315 | TB-500 | CPC | CPC-2605-B1397 | Kestrel | 2026-Q2 | 99.59 | 5.70 | 102.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020086 | Tirzepatide | SWB | SWB-2505-R8575 | Janoshik | 2025-Q2 | 98.84 | 2.51 | 104.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019497 | Liraglutide | JEEP | JEEP-2411-B9021 | PeptideMeter | 2025-Q2 | 98.71 | 4.28 | 103.2 | Laboratory-retained | 0 | PASS |
| AX-2024-005101 | TB-500 | SSA | SSA-2406-H7589 | Janoshik | 2024-Q4 | 98.53 | 4.45 | 89.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004377 | L-Glutathione (reduced) | FGP | FGP-2405-E9260 | Medutest | 2024-Q3 | 99.93 | 5.77 | — | Buyer-sourced | 0 | PASS |